About INVO Bioscience®

We are a medical device company focused on creating simplified, lower cost treatments for patients diagnosed with infertility. Our solution, the INVO® Procedure, is a disruptive new technology. The INVO Procedure is a revolutionary in vivo method of vaginal incubation that offers patients a more natural and intimate experience.

Our lead product, the INVOcell®, is a patented medical device used in infertility treatment and is considered an Assisted Reproductive Technology (ART). The INVOcell is the first Intravaginal Culture (IVC) system in the world used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development, as an alternative to traditional In Vitro Fertilization (IVF) and Intrauterine Insemination (IUI).

Our mission is to increase access to care and expand fertility treatment across the globe with a goal to lower the cost of care and increase availability of care.


Unlike conventional assisted reproductive techniques such as In Vitro Fertilization (IVF), where the eggs and sperm develop into embryos in a laboratory, the INVO Procedure is an in vivo method that utilizes the women’s vagina as an incubator to support fertilization and early embryo development.

The key features and benefits of the INVOcell device and INVO Procedure are many.

  • The INVO Procedure provides a more natural and stable incubation environment.

  • The INVO Procedure provides psychological benefits to patients by promoting greater involvement by couples.

  • The INVO Procedure offers a secure and affordable treatment reducing the risk of incorrect embryo transfers.

  • The INVO Procedure lowers the cost of fertility treatments while increasing geographic accessibility to many more patients with equivalent efficacy and pregnancy rates compared to traditional IVF.